Annual trading update for the year ending September 30th, 2022
- Bruntwood SciTech post pre-tax profit of £114m (2021: £17.1m) – the most since its formation in 2018
- Net asset value increases 36% to £321.1m and total assets under management hits £858.44m (2021: £647.4m)
- £91m of capital investment including first move into Scotland and significant progress on key developments
- Completions of Enterprise Wharf and No.1 Birmingham Health Innovation Campus and construction kick off at Glasgow’s Met Tower and Citylabs 4.0 to come in 2023
Profits grew significantly in 2022 hitting £114m, up from £17.1m in 2021, following the completion and successful letting-up of several key assets and the growing recognition of life sciences as a distinct real estate asset class, all of which contributed to significant revaluation gains.
This included the first two phases of Circle…
